Wynn Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.7M Sell
19,841
-15
-0.1% -$1.47K 0.75% 38
2026
Q2
$2.05M Sell
19,856
-105
-0.5% -$9.37K 0.92% 34
2026
Q1
$1.43M Sell
19,961
-181
-0.9% -$13.9K 0.74% 40
2025
Q4
$1.6M Buy
20,142
+81
+0.4% +$6.39K 0.78% 37
2025
Q3
$1.51M Buy
20,061
+340
+2% +$23.3K 0.73% 37
2025
Q2
$1.36M Buy
19,721
+251
+1% +$16.5K 0.73% 39
2025
Q1
$1.32M Buy
19,470
+530
+3% +$31.7K 0.78% 38
2024
Q4
$850K Sell
18,940
-215
-1% -$12.1K 0.54% 49
2024
Q3
$1.2M Buy
19,155
+1,280
+7% +$74.7K 0.79% 39
2024
Q2
$1.06M Buy
17,875
+260
+1% +$16.3K 0.78% 38
2024
Q1
$1.4M Buy
17,615
+413
+2% +$31.5K 1.09% 32
2023
Q4
$1.36M Buy
+17,202
New +$1.22M 1.11% 29

Other funds holding CVS

Wynn Capital's CVS Position: Q3 2026 in Review

Wynn Capital reduced its CVS Health (CVS) stake by 0.08% in Q3 2026, selling an estimated $1.47K and leaving 19,841 shares worth $1.7M. The position accounts for 0.75% of the portfolio, ranked #38.

Wynn Capital first reported a position in CVS in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.05M in Q2 2026. 1,976 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Wynn Capital held 19,841 shares of CVS Health worth $1.7M as of Q3 2026.
  • Wynn Capital sold 15 CVS Health shares in Q3 2026, an estimated $1.47K.
  • CVS Health made up 0.75% of Wynn Capital's portfolio in Q3 2026, its #38 holding.
  • Wynn Capital first reported a position in CVS Health in Q4 2023 and has held it in 12 quarters since.
  • Wynn Capital's CVS Health position peaked at $2.05M in Q2 2026.
  • 1,976 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Wynn Capital's 13F filing for Q3 2026, filed 13 Oct 2026.